Physician

Abdi Abbassi, M.D.

According to 2025 Medicare claims, Abdi Abbassi, M.D. (NPI: 1831183938) practices gastroenterology in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is DIGESTIVE DISEASE CONSULTANTS (NPI: 1710251921; TIN: 421656000) and primary practice location at 32204-4416.

Abbassi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 850 traditional Medicare patients, billed 3,409 HCPCS/CPT codes, and received $334,349 in Medicare payments. The top billing code was 45380 (Biopsy of large bowel using a flexible endoscope). Part D data shows 3,559 prescription claims across 1,131 beneficiaries totaling $2,371,231 in drug costs, led by Epclusa (Sofosbuvir/Velpatasvir). 2020 DME data shows 12 claims. Open Payments data shows 51 records totaling $1,052. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $565,476 to $334,349. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,480	5,544	$565,476
2016	1,422	4,180	$415,545
2017	1,321	4,250	$392,559
2018	1,206	3,940	$383,983
2019	1,343	4,256	$435,570
2020	1,194	4,327	$428,362
2021	1,257	4,324	$446,126
2022	1,041	3,313	$313,671
2023	814	3,763	$329,760
2024	850	3,409	$334,349

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	709	2,136	$3,499,761
2016	556	1,743	$2,018,235
2017	474	1,627	$2,416,028
2018	556	2,035	$1,598,667
2019	607	2,207	$2,002,339
2020	664	2,295	$1,976,795
2021	754	2,465	$1,930,922
2022	799	2,658	$1,551,691
2023	899	2,960	$1,823,463
2024	1,131	3,559	$2,371,231

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$1,605
2017	N/R	N/R	N/R
2018	N/R	12	$1,695
2019	N/R	N/R	N/R
2020	N/R	12	$55
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45380	Biopsy of large bowel using a flexible endoscope	348	349	$139
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	346	347	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	388	578	$101
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	324	330	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	230	247	$74

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epclusa	Sofosbuvir/Velpatasvir	14	392	$340,421
Skyrizi On-Body	Risankizumab-Rzaa	11	616	$251,535
Entyvio	Vedolizumab	23	1,179	$199,824
Creon	Lipase/Protease/Amylase	40	1,566	$163,125
Rinvoq	Upadacitinib	15	436	$140,201

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$1,052	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdi Abbassi, M.D.?

Tedicare shows public-source Medicare data for Abdi Abbassi, M.D. (NPI 1831183938), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdi Abbassi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdi Abbassi, M.D.?

Abdi Abbassi, M.D. is linked to DIGESTIVE DISEASE CONSULTANTS (billing NPI 1710251921) in the available physician profile data.

Does Abdi Abbassi, M.D. have Open Payments data?

Abdi Abbassi, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.